Hirofumi Taji
Okazaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
RB and CHASER as induction therapy for transplant-eligible mantle cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: June 29, 2025
Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure.
Journal: Hematology (Amsterdam, Netherlands)
Published: May 15, 2023
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Journal: International journal of hematology
Published: October 22, 2021
Long-term follow-up of patients with ATL after autologous stem cell transplantation.
Journal: Bone marrow transplantation
Published: April 06, 2021
Long-term engraftment stability of umbilical cord blood cells preserved in -135 °C mechanical freezers.
Journal: Leukemia research
Published: February 20, 2021
Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey.
Journal: International journal of hematology
Published: October 08, 2020
Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia.
Journal: Internal medicine (Tokyo, Japan)
Published: July 03, 2020
High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey.
Journal: International journal of hematology
Published: July 09, 2019
Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
Journal: British journal of haematology
Published: June 18, 2019
Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
Journal: International journal of hematology
Published: September 13, 2018
Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 06, 2017
Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Journal: Annals of hematology
Published: February 17, 2016
Last Updated: 09/26/2026